The treatment of wegener's granulomatosis with glucocorticoids and methotrexate

Arthritis & Rheumatism

Volumn 35, Issue 11, 1992, Pages 1322-1329

  Hoffman, Gary S ^a   Leavitt, Randi Y ^a   Kerr, Gail S ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DISEASE ACTIVITY; DOSE LIVER FUNCTION RELATION; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MORBIDITY; MOUTH ULCER; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; REMISSION; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMAN; MALE; METHOTREXATE; MIDDLE AGE; PILOT PROJECTS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; TREATMENT FAILURE; WEGENER'S GRANULOMATOSIS;

EID: 0026564405     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780351113     Document Type: Article

References (36)

1. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)
2. The use of alkylating agents in the treatment of Wegener's granulomatosis
3. Wegener's granulomatosis: studies in eighteen patients and a review of the literature
4. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years
5. Wegener granulomatosis: an analysis of 158 patients
6. Treatment of Wegener's granulomatosis with intermittent high‐dose intravenous cyclophosphamide
7. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis
8. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis
9. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis
10. Anti‐neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastolytic enzyme
11. Cytotoxic drugs: their clinical application to the rheumatic diseases
12. Stage adapted treatment of Wegener's granulomatosis
13. Wegener's granulomatosis: observations on treatment with antimicrobial agents
14. Sulfamethoxazole‐trimethoprim therapy for Wegener's granulomatosis
15. A controlled two center trial of parenteral methotrexate therapy for refractory rheumatoid arthritis
16. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial
17. Weekly pulse methotrexate in rheumatoid arthritis
18. Efficacy of low dose methotrexate in rheumatoid arthritis
19. The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis
20. Methotrexate therapy in rheumatoid arthritis: 2‐year retrospective followup study
21. Methotrexate in rheumatoid arthritis: indications, contraindications, efficacy and safety
22. Oral methotrexate for chronic rheumatoid arthritis ulcerations
23. Combined therapy with methotrexate and prednisone in polyarteritis nodosa
24. Immunosuppressive therapy in connective tissue disease other than rheumatoid arthritis
25. Methotrexate therapy of Wegener's granulomatosis
26. Treatment of Takayasu's arteritis with methotrexate (abstract)
27. Immunologic studies of rheumatoid arthritis patients treated with methotrexate
28. Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis: evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression
29. The effects of methotrexate on the production and activity of interleukin‐1
30. Methotrexate inhibits polymorphonuclear leukocyte Chemotaxis in psoriasis
31. 4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate
32. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells
33. Complications of immunosuppression associated with weekly low dose methotrexate
34. Rheumatoid arthritis, methotrexate therapy, and Pneumocystis carinii pneumonia
35. Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia
36. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis